A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis
Abstract
Objective: To explore the antiarthritic potential of a novel synthetic cannabinoid acid, Hebrew University–320 (HU‐320), in the DBA/1 mouse model of arthritis, and to investigate in vitro antiinflammatory and immunosuppressive effects of HU‐320 on macrophages and lymphocytes. Methods: DBA/1 mice were immunized with bovine type II collagen (CII) to induce arthritis and then injected intraperitoneally daily with HU‐320. The effects of treatment on arthritic changes in hind feet were assessed clinically and histologically, and draining lymph node responses to CII were assayed. Murine splenic and human blood lymphocytes were cultured to study the effect of HU‐320 on polyclonal mitogenic stimulation. Macrophage cultures were set up to evaluate in vitro effects of HU‐320 on production of tumor necrosis factor α (TNFα) and reactive oxygen intermediates (ROIs). The effect of HU‐320 administration on lipopolysaccharide‐induced serum TNF levels was assayed using C57BL/6 mice. Bioactive TNF production was measured using BALB/c clone 7 target cells. Evaluation of HU‐320 psychoactivity was performed using established laboratory tests on Sabra mice. Results: Systemic daily administration of 1 and 2 mg/kg HU‐320 ameliorated established CII‐induced arthritis. Hind foot joints of treated mice were protected from pathologic damage. CII‐specific and polyclonal responses of murine and human lymphocytes were down‐modulated. HU‐320 inhibited production of TNF from mouse macrophages and of ROIs from RAW 264.7 cells and suppressed the rise in serum TNF level following endotoxin challenge. HU‐320 administration yielded no adverse psychotropic effects in mice. Conclusion: Our studies show that the novel synthetic cannabinoid acid HU‐320 has strong antiinflammatory and immunosuppressive properties while demonstrating no psychoactive effects. The profound suppressive effects on cellular immune responses and on the production of proinflammatory mediators all indicate its usefulness as a novel nonpsychoactive, synthetic antiinflammatory product.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Administration of CBD or its synthetic analogs attenuates clinical signs of arthritis and joint damage in CIA.
“Administration of CBD, or its synthetic analogs, attenuates clinical signs of arthritis and joint damage, while having an immunosuppressant effect in CIA (Haj et al, 2015;Malfait et al, 2000;Sumariwalla et al, 2004).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Sumariwalla et al, 2004
Administration of CBD or its synthetic analogs has an immunosuppressant effect in CIA.
“Administration of CBD, or its synthetic analogs, attenuates clinical signs of arthritis and joint damage, while having an immunosuppressant effect in CIA (Haj et al, 2015;Malfait et al, 2000;Sumariwalla et al, 2004).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Sumariwalla et al, 2004
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682 · see citing works
Self-citationMoreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R., Weaver, A. L., Ettlinger, R. E., Cohen, S. B., Koopman, W. J., Mohler, K. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,620 · see citing works
Etanercept Therapy in Rheumatoid Arthritis
Moreland, L. W., Schiff, M. H., Baumgartner, S. W., Tindall, E. A., Fleischmann, R. M., Bulpitt, K. J., Weaver, A. L., Keystone, E. C., Furst, D. E., Mease, P. J., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00004 · Cited by 1,403 · see citing works
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315 · see citing works
Self-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,252 · see citing works
Self-citationLee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,250 · see citing works
Use of MTT colorimetric assay to measure cell activation
Gerlier, D., & Thomasset, N. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90215-2 · Cited by 1,203 · see citing works
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P. J., Katsikis, P. D., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038 · see citing works
Self-citationImmunisation against heterologous type II collagen induces arthritis in mice
COURTENAY, J. S., Dallman, M. J., Dayan, A. D., Martin, A. J., & Mosedale, B. (1980) · Nature · doi:10.1038/283666a0 · Cited by 1,025 · see citing works
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 991 · see citing works
Self-citationFeldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81109-5 · Cited by 978 · see citing works
Self-citationFunctional macrophage cell lines transformed by abelson leukemia virus
Raschke, W. C., Baird, S. M., Ralph, P., & Nakoinz, I. (1978) · Cell · doi:10.1016/0092-8674(78)90101-0 · Cited by 906 · see citing works
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669 · see citing works
Self-citationAction of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608 · see citing works
Constituents of Cannabis sativa L. XVII. A review of the natural constituents
Turner, C. E., Elsohly, M. A., & Boeren, E. G. (1980) · Journal of Natural Products · doi:10.1021/np50008a001 · Cited by 599 · see citing works
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 574 · see citing works
Self-citationCannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 511 · see citing works
Self-citationMechoulam, R. (1970) · Science · doi:10.1126/science.168.3936.1159 · Cited by 494 · see citing works
Self-citationMechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486 · see citing works
Self-citationPharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
Fride, E., & Mechoulam, R. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90468-w · Cited by 448 · see citing works
Self-citationStructural studies on cartilage collagen employing limited cleavage and solubilization with pepsin
Miller, E. J. (1972) · Biochemistry · doi:10.1021/bi00776a005 · Cited by 416 · see citing works
Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
Martin, B. R., Compton, D. M., Thomas, B. F., Prescott, W. R., Little, P., Razdan, R. K., Johnson, M. R., Melvin, L. S., Mechoulam, R., & Ward Susan, J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90349-7 · Cited by 410 · see citing works
Self-citationShohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337 · see citing works
Self-citationMauri, C., Williams, R. O., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260716 · Cited by 309 · see citing works
Self-citationAntipsychotic effect of cannabidiol.
Zuardi, A. W., Morais, S. L., Guimarães, F. S., & Mechoulam, R. (1995) · PubMed · Cited by 264 · see citing works
Self-citationRothstein, J. L., & Schreiber, H. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.607 · Cited by 259 · see citing works
Biphasic Effects of Anandamide
Sulcova, E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00422-x · Cited by 256 · see citing works
Collagen arthritis as a relevant model for rheumatoid arthritis. evidence pro and con
Trentham, D. E. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250801 · Cited by 254 · see citing works
Cannabinoid receptors and immunity
Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235 · see citing works
Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., & Lesslauer, W. (1992) · PubMed Central · Cited by 232 · see citing works
Cannabinoids and brain injury: therapeutic implications
Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229 · see citing works
Self-citationCompton, D. M., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11216-0 · Cited by 216 · see citing works
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M. H., Vogel, Z., Barg, J., Bayewitch, M. L., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 192 · see citing works
Self-citationThe ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice
Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06900.x · Cited by 189 · see citing works
Sebbag, M., Parry, S. L., Brennan, F. M., & Feldmann, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270308 · Cited by 178 · see citing works
Self-citationMalfait, A., Butler, D., Presky, D. H., Maini, R. N., Brennan, F. M., & Feldmann, M. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00485.x · Cited by 142 · see citing works
Self-citationFrom gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis
Mechoulam, R., & Ben‐Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 139 · see citing works
Self-citationAnalgesic and antiinflammatory activity of constituents ofCannabis sativa L.
Formukong, E. A., EVANS, A. T., & Evans, F. J. (1988) · Inflammation · doi:10.1007/bf00915771 · Cited by 130 · see citing works
Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90160-9 · Cited by 111 · see citing works
BURSTEIN, S. H., Audette, C. A., Breuer, A., Devane, W. A., Colodner, S., Doyle, S. A., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00095a007 · Cited by 99 · see citing works
Self-citationZurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1 · Cited by 96 · see citing works
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
Guimarães, F. S., Aguiar, J. C. D., Mechoulam, R., & Breuer, A. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90027-2 · Cited by 89 · see citing works
Self-citationTetrahydrocannabinol inhibition of macrophage nitric oxide production
Coffey, R. G., Yamamoto, Y., Snella, E. M., & Pross, S. H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00356-5 · Cited by 77 · see citing works
T-cell-dependent pathways in rheumatoid arthritis
Panayi, G. S. (1997) · Current Opinion in Rheumatology · doi:10.1097/00002281-199705000-00010 · Cited by 77 · see citing works
Brenner, T., Yamin, A., Abramsky, O., & Gallily, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91468-8 · Cited by 63 · see citing works
Self-citationAntioxidants Attenuate Acute Toxicity of Tumor Necrosis Factor-alpha Induced by Brain Injury in Rat
Trembovler, V., Beit‐Yannai, E., Younis, F. M., Gallily, R., Horowitz, M., & Shohami, E. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313640 · Cited by 61 · see citing works
Self-citationDajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M., Dayton, M. T., & Mir, G. (1999) · PubMed · Cited by 57 · see citing works
Rodent models of arthritis: relevance for human disease
Williams, R. O. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00785.x · Cited by 55 · see citing works
Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages
Catterall, J. R., Black, C. M., Leventhal, J. P., Rizk, N. W., Wachtel, J. S., & Remington, J. S. (1987) · Infection and Immunity · doi:10.1128/iai.55.7.1635-1640.1987 · Cited by 45 · see citing works
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
Fride, E., & Shohami, E. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00001 · Cited by 44 · see citing works
Self-citationAjulemic Acid (CT3) A Potent Analog of the Acid Metabolites of THC
BURSTEIN, S. H. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399473 · Cited by 40 · see citing works
Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages
Avron, A., & Gallily, R. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.2.264 · Cited by 35 · see citing works
Self-citationLooking Back at Cannabis Research
Mechoulam, R. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399509 · Cited by 33 · see citing works
Self-citationCarpenter, E. A., Fray, L. M., & Gormley, E. P. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00760.x · Cited by 26 · see citing works
Combination therapy with DMARDs and biological agents in collagen-induced arthritis.
Williams, R. O., Malfait, A., Butler, D., Walmsley, M. J., Feldmann, M., & Maini, R. N. (1999) · PubMed · Cited by 9 · see citing works
Self-citationMitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728 · see citing works
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 710 · see citing works
The CB2 receptor and its role as a regulator of inflammation
Turcotte, C., Blanchet, M., Laviolette, M., & Flamand, N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2300-4 · Cited by 598 · see citing works
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555 · see citing works
“used another synthetic nonpsychoactive cannabinoid, HU-320, and demonstrated that this compound improved already established arthritis in mice [86].”
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.059 · Cited by 573 · see citing works
Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515 · see citing works
Cannabinoids and Pain: New Insights From Old Molecules
Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 417 · see citing works
Bioactive lipids, inflammation and chronic diseases
Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 368 · see citing works
Fernández‐Ruíz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R. G., Mechoulam, R., & Martínez-Orgado, J. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 356 · see citing works
Self-citationDonvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 256 · see citing works
Rufino, A. T., Ribeiro, M. P., Sousa, C., Judas, F., Salgueiro, L., Cavaleiro, C., & Mendes, A. F. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.018 · Cited by 227 · see citing works
Cannabidiol in Humans—The Quest for Therapeutic Targets
Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 199 · see citing works
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 181 · see citing works
Cannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177 · see citing works
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Cabral, G. A., Rogers, T. J., & Lichtman, A. H. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9615-z · Cited by 141 · see citing works
Cannabinoids and autoimmune diseases: A systematic review
Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 143 · see citing works
Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation
BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 135 · see citing works
Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists
Lunn, C. A., Reich, E., Fine, J. S., Lavey, B. J., Kozlowski, J. A., Hipkin, R. W., Lundell, D. J., & Bober, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707480 · Cited by 119 · see citing works
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids
Hanuš, L. O. (2008) · Medicinal Research Reviews · doi:10.1002/med.20135 · Cited by 110 · see citing works
Cannabinoids, inflammation, and fibrosis
Zurier, R. B., & BURSTEIN, S. H. (2016) · The FASEB Journal · doi:10.1096/fj.201600646r · Cited by 112 · see citing works
Ben‐Shabat, S., Hanuš, L. O., Katzavian, G., & Gallily, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050709m · Cited by 106 · see citing works
Self-citationWu, H., Huang, C., Lin, Y., Wang, C., & Jan, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.06.023 · Cited by 102 · see citing works
Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors
Hanu, L. O., Tchilibon, S., Ponde, D. E., Breuer, A., Fride, E., & Mechoulam, R. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b416943c · Cited by 103 · see citing works
Self-citationEndocannabinoids in immune regulation and immunopathologies
Rahaman, O., & Ganguly, D. (2021) · Immunology · doi:10.1111/imm.13378 · Cited by 102 · see citing works
Pathophysiology and treatment of pain in joint disease☆
Schaible, H., Schmelz, M., & Tegeder, I. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.011 · Cited by 98 · see citing works
Formation of B and T cell subsets require the cannabinoid receptor CB2
Ziring, D., Wei, B., Velázquez, P., Schrage, M. I., Buckley, N. E., & Braun, J. G. (2006) · Immunogenetics · doi:10.1007/s00251-006-0138-x · Cited by 95 · see citing works
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis
Fukuda, S., Kohsaka, H., Takayasu, A., Yokoyama, W., Miyabe, C., Miyabe, Y., Harigai, M., Miyasaka, N., & Nanki, T. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-275 · Cited by 93 · see citing works
Anti-TNF therapy: Where have we got to in 2005?
Feldmann, M., Brennan, F. M., Foxwell, B. M. J., Taylor, P. C., Williams, R. O., & Maini, R. N. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.09.006 · Cited by 92 · see citing works
Self-citationThe Role of Nerves in Skeletal Development, Adaptation, and Aging
Tomlinson, R. E., Christiansen, B., Giannone, A. A., & Genetos, D. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00646 · Cited by 90 · see citing works
Réus, G. Z., Stringari, R. B., Ribeiro, K. F., Luft, T., Abelaira, H. M., Fries, G. R., Aguiar, B. W., Kapczinski, F., Hallak, J. E., Zuardi, A. W., et al. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00579.x · Cited by 86 · see citing works
Ajulemic acid: A novel cannabinoid produces analgesia without a “high”
BURSTEIN, S. H., Karst, M., Schneider, U., & Zurier, R. B. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.010 · Cited by 82 · see citing works
Mejía, S., Duerr, F. M., Griffenhagen, G. M., & McGrath, S. (2021) · Journal of the American Animal Hospital Association · doi:10.5326/jaaha-ms-7119 · Cited by 78 · see citing works
Cannabinoids and Bone: Friend or Foe?
Idris, A. I., & Ralston, S. H. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9378-8 · Cited by 75 · see citing works
Malek, N., Mrugala, M., Makuch, W., Kolosowska, N., Przewlocka, B., Binkowski, M., Czaja, M., Morera, E., Di Marzo, V., & Starowicz, K. (2015) · Pain · doi:10.1097/j.pain.0000000000000132 · Cited by 63 · see citing works
The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2
Fulmer, M. L., & Thewke, D. P. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180206161457 · Cited by 64 · see citing works
Dunn, S. L., Wilkinson, J. M., Crawford, A., Bunning, R. A. D., & Le Maitre, C. L. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2015.0001 · Cited by 62 · see citing works
Wang, R., Meng, H., Kou, X., Sui, B., Sanmillan, M. L., Zhang, X., Liu, D., Tian, J., Yu, W., Chen, C., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.026 · Cited by 61 · see citing works
Jan, T., Su, S.-T., Wu, H., & Liao, M.-H. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.01.015 · Cited by 61 · see citing works
Involvement of the endocannabinoid system in osteoarthritis pain
Porta, C. L., Bura, S. A., Negrete, R., & Maldonado, R. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12468 · Cited by 61 · see citing works
Robinson, R. H., Meissler, J. J., Deckman, J. M., Gaughan, J. P., Adler, M. W., & Eisenstein, T. K. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9485-1 · Cited by 60 · see citing works
Pain measurements and side effect profile of the novel cannabinoid ajulemic acid
Salim, K., Schneider, U., Burstein, S., Hoy, L., & Karst, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.010 · Cited by 58 · see citing works
Lipids as targets for novel anti-inflammatory therapies
Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 57 · see citing works
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis
Lowin, T., Schneider, M., & Pongratz, G. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000590 · Cited by 55 · see citing works
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice
Sophocleous, A., Börjesson, A. E., Salter, D. M., & Ralston, S. H. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.04.020 · Cited by 54 · see citing works
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Scheau, C., Căruntu, C., Bădărău, I. A., Scheau, A.-E., Docea, A. O., Călina, D. C., & Căruntu, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060494 · Cited by 54 · see citing works
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis
Gui, H., Tong, Q., Qu, W., Mao, C.-M., & Dai, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.006 · Cited by 54 · see citing works
Selective breeding for dominant and submissive behavior in Sabra mice
Feder, Y., Nesher, E., Ogran, A., Kreinin, A., Malatyńska, E., Yadid, G., & Pinhasov, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.03.018 · Cited by 54 · see citing works
An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Wang, X., Zhang, H., Liu, Y., Yang, X., Yang, B., Li, H., & Chen, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106810 · Cited by 57 · see citing works
Andersson, A. K., Sumariwalla, P. F., McCann, F. E., Amjadi, P., Chang, C., McNamee, K., Tornehave, D., Haase, C., Agersø, H., Stennicke, V. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30460 · Cited by 50 · see citing works
Self-citationTherapeutic Potential of Cannabinoid-Based Drugs
Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49 · see citing works
Synthetic Strategies for (−)‐Cannabidiol and Its Structural Analogs
Jung, B., Lee, J. K., Kim, J., Kang, E. K., Han, S. Y., Lee, H., & Choi, I. S. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201901179 · Cited by 48 · see citing works
Dunn, S. L., Wilkinson, J. M., Crawford, A., Le Maitre, C. L., & Bunning, R. A. D. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.016 · Cited by 46 · see citing works
Potential anti-inflammatory actions of the elmiric (lipoamino) acids
BURSTEIN, S. H., Adams, J. K., Bradshaw, H. B., Fraioli, C., Rossetti, R. G., Salmonsen, R. A., Shaw, J. W., Walker, J. M., Zipkin, R. E., & Zurier, R. B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.03.026 · Cited by 46 · see citing works
The Current and Potential Application of Medicinal Cannabis Products in Dentistry
Lowe, H. I. C., Toyang, N. J., Steele, B., Bryant, J., Ngwa, W. F., & Nedamat, K. (2021) · Dentistry Journal · doi:10.3390/dj9090106 · Cited by 45 · see citing works
Activation of cannabinoid receptors prevents antigen‐induced asthma‐like reaction in guinea pigs
Giannini, L., Nistri, S., Mastroianni, R., Cinci, L., Vannacci, A., Mariottini, C., Passani, M. B., Mannaioni, P. F., Bani, D., & Masini, E. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00258.x · Cited by 45 · see citing works
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials
Burstein, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070115 · Cited by 44 · see citing works
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
Mesa, X. M. R., Vergara, A. F. M., Bolaños, L. A. C., Guevara-Moriones, N., Piñeros, A. L. M., & González, S. P. S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0183 · Cited by 43 · see citing works
Cannabimimetic Properties of Ajulemic Acid
Vann, R. E., Cook, C. D., Martin, B. R., & Wiley, J. L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111625 · Cited by 41 · see citing works
Yuan, X., Wang, Q., Su, W., Li, H., Wu, C., Gao, F., Xiang, H.-C., Zhu, H., Lin, L., Hu, X., et al. (2018) · Journal of Pain Research · doi:10.2147/jpr.s171664 · Cited by 39 · see citing works
Gentili, M., Ronchetti, S., Ricci, E., Paola, R. D., Gugliandolo, E., Cuzzocrea, S., Bereshchenko, O., Migliorati, G., & Riccardi, C. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.005 · Cited by 38 · see citing works
Endocannabinoids and liver disease – review
Gabbay, E., Avraham, Y., Ilan, Y., Israeli, E., & Berry, E. M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01180.x · Cited by 38 · see citing works
Cannabinoids in pain and inflammation
Mbvundula, E. C., Rainsford, K. D., & Bunning, R. A. D. (2004) · Inflammopharmacology · doi:10.1163/1568560041352275 · Cited by 36 · see citing works
Marijuana Use and Brain Immune Mechanisms
Cabral, G. A., & Jamerson, M. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801284-0.00008-7 · Cited by 33 · see citing works
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Veiga, M., Azevedo‐Silva, J., & Fernandes, J. C. (2023) · Pharmaceuticals · doi:10.3390/ph16020155 · Cited by 35 · see citing works
Stebulis, J. A., Johnson, D. R., Rossetti, R. G., BURSTEIN, S. H., & Zurier, R. B. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.09.004 · Cited by 34 · see citing works
Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi‐Puttini, P., Batticciotto, A., Atzeni, F., Bazzichi, L. M., Franco, M. D., Salaffi, F., Marotto, D., Ceribelli, A., Ablin, J. N., & Häuser, W. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1665997 · Cited by 33 · see citing works
Andersson, C., Wenander, C. S., Usher, P. A., Hebsgaard, J. B., Søndergaard, B. C., Rønø, B., Mackay, C. R., Friedrichsen, B. N., Chang, C., Tang, R., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12338 · Cited by 32 · see citing works
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
Kogan, N. M., Lavi, Y., Topping, L. M., Williams, R. O., McCann, F. E., Yekhtin, Z., Feldmann, M., Gallily, R., & Mechoulam, R. (2021) · Molecules · doi:10.3390/molecules26185601 · Cited by 32 · see citing works
Self-citationEffect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain
Mitchell, V. A., Aslan, S. C., Safaei, R., & Vaughan, C. W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.019 · Cited by 31 · see citing works
Wu, H.-Y., Chang, A.-C., Wang, C., Kuo, F.-H., Lee, C.-Y., Liu, D.-Z., & Jan, T. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.05.003 · Cited by 31 · see citing works
Cannabinoids in the treatment of rheumatic diseases: Pros and cons
Sarzi‐Puttini, P., Ablin, J. N., Trabelsi, A., Fitzcharles, M., Marotto, D., & Häuser, W. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102409 · Cited by 30 · see citing works
Comparative Analysis of the Behavioral and Biomolecular Parameters of Four Mouse Strains
Nesher, E., Peskov, V., Rylova, A., Raz, O., & Pinhasov, A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9544-0 · Cited by 27 · see citing works
Cannabidiol as an immune modulator: A comprehensive review
Mujahid, K., Rasheed, M. S., Sabir, A., Nam, J., Ramzan, T., Ashraf, W., & Imran, I. (2025) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-025-00005-7 · Cited by 31 · see citing works
HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid
Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26 · see citing works
Self-citationCannabinoids in the Management of Musculoskeletal Pain
Madden, K., van der Hoek, N., Chona, S., George, A., Dalchand, T., Baldawi, H., Mammen, G., & Bhandari, M. (2018) · JBJS Reviews · doi:10.2106/jbjs.rvw.17.00153 · Cited by 25 · see citing works
Cannabinoids against pain. Efficacy and strategies to reduce psychoactivity: a clinical perspective
Karst, M., & Wippermann, S. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802691951 · Cited by 24 · see citing works
The cannabinoid acids, analogs and endogenous counterparts
BURSTEIN, S. H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.038 · Cited by 23 · see citing works
Ismail, M., Hasan, H. A., El-Orfali, Y., Ismail, H. F., & Khawaja, G. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/9365464 · Cited by 22 · see citing works
Preclinical science regarding cannabinoids as analgesics: An overview
Lynch, M. (2005) · Pain Research and Management · doi:10.1155/2005/169093 · Cited by 20 · see citing works
Do cannabinoids have a therapeutic role in transplantation?
Nagarkatti, M., Rieder, S. A., Hegde, V. L., Kanada, S., & Nagarkatti, P. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.05.006 · Cited by 20 · see citing works
Molecular Mechanisms for the Inflammation-Resolving Actions of Lenabasum
BURSTEIN, S. H. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000083 · Cited by 19 · see citing works
Paland, N., Hamza, H., Pechkovsky, A., Aswad, M., Shagidov, D., & Louria‐Hayon, I. (2023) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10509 · Cited by 28 · see citing works
Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases
Quezada, S. M., & Cross, R. K. (2019) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0670-0 · Cited by 19 · see citing works
Cannabinoids: Novel Therapies For Arthritis?
Dunn, S. L., Wilkinson, J. M., Crawford, A., Maitre, C. L. L., & Bunning, R. A. D. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.20 · Cited by 18 · see citing works
Cannabidiol and Other Cannabinoids in Demyelinating Diseases
Navarrete, C. M., García‐Martín, A., Rolland, A. P., DeMesa, J., & Muñóz, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062992 · Cited by 19 · see citing works
Petrella, C., Agostini, S., Alemà, G., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., & Broccardo, M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01569.x · Cited by 18 · see citing works
Xin, Y., Tang, A., Pan, S., & Zhang, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.793750 · Cited by 17 · see citing works
Delsing, D. J. M., Leijten, F. P., Arts, K., van Eenennaam, H., Garritsen, A., Gijbels, M. J., de Winther, M. P. J., & van Elsas, A. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010015 · Cited by 17 · see citing works
Pathophysiology of Portal Hypertension
Morales‐Ruiz, M., Rodríguez‐Vita, J., Ribera, J., & Jiménez, W. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_144 · Cited by 17 · see citing works
Cannabinoids in Periodontology: Where Are We Now?
Rendón, Y. A. C., Garzon, H. S., Bueno‐Silva, B., Arce, R. M., & Suárez, L. J. (2023) · Antibiotics · doi:10.3390/antibiotics12121687 · Cited by 16 · see citing works
Gusho, C., & Court, T. (2020) · Cureus · doi:10.7759/cureus.7375 · Cited by 16 · see citing works
Spittler, A. P., Helbling, J. E., McGrath, S., Gustafson, D. L., Santangelo, K. S., & Sadar, M. J. (2021) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.13026 · Cited by 16 · see citing works
Endocannabinoids in arthritis: current views and perspective
Barrie, N., Kuruppu, V., Manolios, E., Ali, M., Moghaddam, M. J., & Manolios, N. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13146 · Cited by 15 · see citing works
Complementary and Alternative Medicine
Quezada, S. M., Briscoe, J. A., & Cross, R. K. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000761 · Cited by 15 · see citing works
Cannabinoid chemistry: an overview
Hanuš, L. O., & Mechoulam, R. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_2 · Cited by 13 · see citing works
Self-citationAlpert, E., Gruzman, A., Lardi‐Studler, B., Cohen, G., Reich, R., & Sasson, S. (2006) · Diabetologia · doi:10.1007/s00125-005-0122-2 · Cited by 13 · see citing works
Cannabis for Rheumatic Disease Pain: a Review of Current Literature
Nowell, W. B., Gavigan, K., & Silverman, S. L. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01065-7 · Cited by 15 · see citing works
- Authors
- Sumariwalla, P. F., Gallily, R., Tchilibon, S., Fride, E., Mechoulam, R., & Feldmann, M.
- Affiliations
- Imperial College London (GB)
- Hebrew University of Jerusalem (IL)
- Ariel University (IL)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-03
- Volume
- 50
- Issue
- 3
- Pages
- 985-998
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2056056547
- Cited by
- 134
- References
- 57
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 4 · 2019: 8 · 2018: 7 · 2017: 4 · 2016: 6 · 2015: 10 · 2014: 7 · 2013: 2 · 2012: 3
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- collagen-induced arthritis, anti-inflammatory activity, immunosuppression, TNF-α, reactive oxygen species, macrophages, lymphocytes, cell-mediated immunity, DBA/1 mice
- MeSH terms
- Animals, Anti-Inflammatory Agents, Arthritis, Experimental, Cannabidiol, Cattle, Cells, Cultured, Central Nervous System, Cyclohexanecarboxylic Acids, Female, Humans, Immunity, Cellular, Immunosuppressive Agents, Joints, Lipopolysaccharides, Lymphocytes, Macrophages, Mice, Inbred BALB C, Mice, Inbred C57BL, Mitosis, Severity of Illness Index, Tumor Necrosis Factor-alpha, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
